documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
16 rows where docket_id = "FDA-2015-N-1355" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 16
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-N-1355-0026 | FDA | None FDA-2015-N-1355 | Use of Ozone-Depleting Substances | Rule | Direct Final Rule | 2017-02-28T05:00:00Z | 2017 | 2 | 2017-02-28T05:00:00Z | 2017-02-28T14:41:22Z | 2017-03866 | 0 | 0 | 09000064824e0d15 | |
| FDA-2015-N-1355-0017 | FDA | None FDA-2015-N-1355 | Attachment 2 Redacted Cetylite adverse drug experience reports re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2017-01-13T17:09:39Z | 0 | 0 | 090000648243807b | |||
| FDA-2015-N-1355-0016 | FDA | None FDA-2015-N-1355 | Attachment 1 Redacted History of Cetylite's DESI proceeding re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2017-01-13T17:06:29Z | 0 | 0 | 090000648243807a | |||
| FDA-2015-N-1355-0022 | FDA | None FDA-2015-N-1355 | Exhibit D A Guidance on the Use of Topical Anesthetics for Naso/Oropharyngeal and Laryngotracheal Procedures Feb. 2006 www.pbm.va.gov re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T18:21:59Z | 0 | 0 | 09000064824380ec | |||
| FDA-2015-N-1355-0023 | FDA | None FDA-2015-N-1355 | Exhibit E Current Cetacaine® Spray label from DailyMed database re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T18:24:02Z | 0 | 0 | 09000064824380ed | |||
| FDA-2015-N-1355-0024 | FDA | None FDA-2015-N-1355 | Exhibit F Current Laryng-0-Jet kit label from DailyMed database re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T18:27:37Z | 0 | 0 | 09000064824380ee | |||
| FDA-2015-N-1355-0018 | FDA | None FDA-2015-N-1355 | Attachment 3 Redacted Information about Cetylite's business status re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2017-01-13T17:12:15Z | 0 | 0 | 09000064824380e7 | |||
| FDA-2015-N-1355-0020 | FDA | None FDA-2015-N-1355 | Exhibit A Guidance for FDA Staff and Industry Marketed Unapproved Drugs Compliance Policy Guide Sec. 440.100 Marketed New Drugs Without Approved NDAs or ANDAs Sept 9, 2011 re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2016-12-27T19:41:10Z | 0 | 0 | 09000064824380e9 | |||
| FDA-2015-N-1355-0019 | FDA | None FDA-2015-N-1355 | Attachment 4 Redacted List of Cetylite's communications with DAAAP re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2017-01-13T17:14:30Z | 0 | 0 | 09000064824380e8 | |||
| FDA-2015-N-1355-0021 | FDA | None FDA-2015-N-1355 | Exhibit C Greenfield, Hittelman, and Glickman Evaluation of Anesthetic Agents on Human Mucous Membrane: An Illustration Experimental Protocol Using Computers NYS Dental Journal (1986): 22-28. re: Comment from Keller and Heckman LLP (Cetylite Industries, Inc.) | Supporting & Related Material | Background Material | 2016-12-27T05:00:00Z | 2016 | 12 | 2017-01-13T16:51:34Z | 0 | 0 | 09000064824380eb | |||
| FDA-2015-N-1355-0003 | FDA | None FDA-2015-N-1355 | Use of Ozone-Depleting Substances | Rule | Direct Final Rule | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T04:00:00Z | 2016-12-28T04:59:59Z | 2016-12-28T02:02:24Z | 2016-25851 | 0 | 0 | 090000648234d51a |
| FDA-2015-N-1355-0007 | FDA | None FDA-2015-N-1355 | Reference 1 -More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems | Supporting & Related Material | Background Material | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T20:08:17Z | 0 | 0 | 09000064823547dd | |||
| FDA-2015-N-1355-0004 | FDA | None FDA-2015-N-1355 | Use of Ozone-Depleting Substances | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T04:00:00Z | 2016-12-28T04:59:59Z | 2016-12-01T14:00:46Z | 2016-25850 | 0 | 0 | 090000648234d577 |
| FDA-2015-N-1355-0005 | FDA | None FDA-2015-N-1355 | Use of Ozone-Depleting Substances | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T04:00:00Z | 2016-12-28T04:59:59Z | 2017-01-31T02:02:25Z | 2016-25852 | 0 | 0 | 090000648234d5d1 |
| FDA-2015-N-1355-0006 | FDA | None FDA-2015-N-1355 | Reference 1 - Bryan Corporation (httplistings.findthecompany.coml12165972Bryan-Corporation-in-Woburn-MA | Supporting & Related Material | Background Material | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T20:06:21Z | 0 | 0 | 09000064823547dc | |||
| FDA-2015-N-1355-0001 | FDA | None FDA-2015-N-1355 | Use of Ozone-Depleting Substances; Request for Comment Concerning Essential-Use Designations | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2015-06-29T04:00:00Z | 2015 | 6 | 2015-06-29T04:00:00Z | 2015-08-29T03:59:59Z | 2015-08-22T01:30:54Z | 2015-15902 | 0 | 0 | 0900006481b5acc4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;